BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ri MH, Ma J, Jin X. Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. J Ethnopharmacol 2021;281:114370. [PMID: 34214644 DOI: 10.1016/j.jep.2021.114370] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Lu JJ, Chen MB, Gao XJ, Zhang Y, Liu YY, Yong Y, Li P. Gross perianal embryonal rhabdomyosarcoma with severe multiple bone metastases throughout the body: a case report. J Int Med Res 2022;50:3000605221087050. [PMID: 35317622 DOI: 10.1177/03000605221087050] [Reference Citation Analysis]
2 Zheng S, Liu B, Guan X. The Role of Tumor Microenvironment in Invasion and Metastasis of Esophageal Squamous Cell Carcinoma. Front Oncol 2022;12:911285. [DOI: 10.3389/fonc.2022.911285] [Reference Citation Analysis]
3 Kumar GS, Moustafa M, Sahoo AK, Malý P, Bharadwaj S. Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy. Life 2022;12:659. [DOI: 10.3390/life12050659] [Reference Citation Analysis]
4 Wang JY, Xing Y, Li MY, Zhang ZH, Jin HL, Ma J, Lee JJ, Zhong Y, Zuo HX, Jin X. Panaxadiol inhibits IL-1β secretion by suppressing zinc finger protein 91-regulated activation of non-canonical caspase-8 inflammasome and MAPKs in macrophages. J Ethnopharmacol 2022;283:114715. [PMID: 34648898 DOI: 10.1016/j.jep.2021.114715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yang Y, Liu Q, Shi X, Zheng Q, Chen L, Sun Y. Advances in plant-derived natural products for antitumor immunotherapy. Arch Pharm Res 2021. [PMID: 34751930 DOI: 10.1007/s12272-021-01355-1] [Reference Citation Analysis]
6 Vergoten G, Bailly C. Molecular docking study of britannin binding to PD-L1 and related anticancer pseudoguaianolide sesquiterpene lactones. J Recept Signal Transduct Res 2021;:1-8. [PMID: 34789056 DOI: 10.1080/10799893.2021.2003816] [Reference Citation Analysis]